These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9324286)

  • 21. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
    Pollicardo N; O'Brien S; Estey EH; al-Bitar M; Pierce S; Keating M; Kantarjian HM
    Leukemia; 1996 Jan; 10(1):27-31. PubMed ID: 8558933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Implications for Differentiating Agents in APL and Metabolic Syndrome.
    Tedesco J; Qualtieri J; Head D; Savani BN; Reddy N
    Ther Adv Hematol; 2011 Jun; 2(3):141-5. PubMed ID: 23556085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
    Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
    Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
    Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
    Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of Early Death in Acute Promyelocytic Leukemia: A Population-Based Analysis.
    Li G; Wu J; Li R; Pan Y; Ma W; Xu J; Nan M; Hou L
    Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e78-e84. PubMed ID: 36567214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program.
    Doria-Rose VP; Harlan LC; Stevens J; Little RF
    Leuk Lymphoma; 2014 Nov; 55(11):2549-55. PubMed ID: 24467221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher body mass index in 16-19 year-old Jewish Adolescents of North African, Middle Eastern and European Origins is a Predictor of Acute Myeloid Leukemia: a cohort of 2.3 million Israelis.
    Shamriz O; Leiba M; Levine H; Derazne E; Keinan-Boker L; Kark JD
    Cancer Causes Control; 2017 Apr; 28(4):331-339. PubMed ID: 28258513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could Acute Myeloid Leukemia Have Presented Even Worse? "Uncommon Cause of Concurrently Multivessel Thrombosis".
    Hazir KE; Simsek EC; Baldan E; Uzun HG; Bulbul H; Yarci B; Ozcan EB
    Arq Bras Cardiol; 2023 Jul; 120(8):20220808. PubMed ID: 37586004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears.
    Eckardt JN; Schmittmann T; Riechert S; Kramer M; Sulaiman AS; Sockel K; Kroschinsky F; Schetelig J; Wagenführ L; Schuler U; Platzbecker U; Thiede C; Stölzel F; Röllig C; Bornhäuser M; Wendt K; Middeke JM
    BMC Cancer; 2022 Feb; 22(1):201. PubMed ID: 35193533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A convolutional neural network-based, quantitative complete blood count scattergram-mapping framework promptly screens acute promyelocytic leukemia with high sensitivity.
    Liao H; Xu Y; Meng Q; Mao Z; Qiao Y; Liu Y; Zheng Q
    Cancer; 2023 Oct; 129(19):2986-2998. PubMed ID: 37254628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
    Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
    Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia.
    Ojeda-Uribe M; Schneider A; Luquet I; Berceanu A; Cornillet-Lefebvre P; Jeandidier E; Lioure B; Ades L; Mauvieux L; Himberlin C
    Eur J Haematol; 2012 Sep; 89(3):267-72. PubMed ID: 22591288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia.
    Chim CS; Wong SY; Pang A; Chu P; Lau JS; Wong KF; Kwong YL
    Leukemia; 2005 Dec; 19(12):2241-6. PubMed ID: 16239915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
    Soma M; Maeda Y; Kasakura S; Yabe H
    Rinsho Ketsueki; 1990 Sep; 31(9):1445-9. PubMed ID: 2246816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An epidemiological investigation of adult acute leukemia in Fujian Province in 2010].
    Clinical Collaborative Group, Hematological Branch of Fujian Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):902-5. PubMed ID: 23363744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism.
    Mazzarella L; Botteri E; Matthews A; Gatti E; Di Salvatore D; Bagnardi V; Breccia M; Montesinos P; Bernal T; Gil C; Ley TJ; Sanz M; Bhaskaran K; Coco FL; Pelicci PG
    Haematologica; 2020 Jun; 105(6):1559-1566. PubMed ID: 31515354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.